354 related articles for article (PubMed ID: 7479633)
1. Predictors of and satisfaction with bilateral prophylactic mastectomy.
Stefanek ME; Helzlsouer KJ; Wilcox PM; Houn F
Prev Med; 1995 Jul; 24(4):412-9. PubMed ID: 7479633
[TBL] [Abstract][Full Text] [Related]
2. Bilateral prophylactic mastectomy decision making: A vignette study.
Stefanek M; Enger C; Benkendorf J; Flamm Honig S; Lerman C
Prev Med; 1999 Sep; 29(3):216-21. PubMed ID: 10479610
[TBL] [Abstract][Full Text] [Related]
3. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
Isern AE; Tengrup I; Loman N; Olsson H; Ringberg A
J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1177-87. PubMed ID: 17938010
[TBL] [Abstract][Full Text] [Related]
4. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C
Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
Metcalfe KA; Esplen MJ; Goel V; Narod SA
Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742
[TBL] [Abstract][Full Text] [Related]
6. Quality of life after bilateral prophylactic mastectomy.
Geiger AM; Nekhlyudov L; Herrinton LJ; Rolnick SJ; Greene SM; West CN; Harris EL; Elmore JG; Altschuler A; Liu IL; Fletcher SW; Emmons KM
Ann Surg Oncol; 2007 Feb; 14(2):686-94. PubMed ID: 17103066
[TBL] [Abstract][Full Text] [Related]
7. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
8. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
[TBL] [Abstract][Full Text] [Related]
9. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
Geiger AM; Yu O; Herrinton LJ; Barlow WE; Harris EL; Rolnick S; Barton MB; Elmore JG; Fletcher SW
Arch Intern Med; 2005 Mar; 165(5):516-20. PubMed ID: 15767526
[TBL] [Abstract][Full Text] [Related]
10. Breast reconstruction after bilateral prophylactic mastectomy in women at high risk for breast cancer.
Eldor L; Spiegel A
Breast J; 2009; 15 Suppl 1():S81-9. PubMed ID: 19775335
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life and patient satisfaction after treatment for breast cancer in northern Taiwan.
Chang JT; Chen CJ; Lin YC; Chen YC; Lin CY; Cheng AJ
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):49-53. PubMed ID: 17482771
[TBL] [Abstract][Full Text] [Related]
13. Initial experiences of women from hereditary breast cancer families after bilateral prophylactic mastectomy: a retrospective study.
Josephson U; Wickman M; Sandelin K
Eur J Surg Oncol; 2000 Jun; 26(4):351-6. PubMed ID: 10873354
[TBL] [Abstract][Full Text] [Related]
14. Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy.
McQuirter M; Castiglia LL; Loiselle CG; Wong N
Oncol Nurs Forum; 2010 May; 37(3):313-20. PubMed ID: 20439215
[TBL] [Abstract][Full Text] [Related]
15. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
16. Mastectomy patients' decision-making for or against immediate breast reconstruction.
Harcourt D; Rumsey N
Psychooncology; 2004 Feb; 13(2):106-15. PubMed ID: 14872529
[TBL] [Abstract][Full Text] [Related]
17. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW
J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829
[TBL] [Abstract][Full Text] [Related]
18. Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer.
Alderman AK; Hawley ST; Waljee J; Mujahid M; Morrow M; Katz SJ
Cancer; 2008 Feb; 112(3):489-94. PubMed ID: 18157830
[TBL] [Abstract][Full Text] [Related]
19. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
[TBL] [Abstract][Full Text] [Related]
20. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
